PARAPLATIN is indicated for the treatment of advanced ovarian carcinoma of epithelial origin in: first-line therapy; second-line therapy, after treatment with other chemotherapeutic agents have failed.
PARAPLATIN is also indicated in the treatment of small cell carcinoma of the lung and squamous cell carcinoma of the head and neck.